Article Details

CANNABIS-DERIVED PHARMACEUTICAL PRODUCTS: THERAPEUTIC, PHARMACOKINETIC AND CLINICAL IMPLICATIONS - A COMPREHENSIVE REVIEW

Ganga Srinivasana * and Deepak Shuklaa

a Department of Pharmaceutics, VES College of Pharmacy, Harshu Advani Memorial Complex, Chembur, Mumbai- 400 074, Maharashtra, India

For Correspondence: E-mail: ganga.srinivasan@ves.ac.in

 

https://doi.org/10.53879/id.61.10.14528


ABSTRACT

Cannabis, a diverse compounded plant with a rich cultural and scientific history, has garnered significant attention due to its therapeutic and medicinal potential. The plant’s main active compounds, phytocannabinoids, notably Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), play important roles in its effects. Cannabis formulations range from traditional herbal preparations to modern innovations like edibles, sprays, topicals and vaporizable products. Achieving consistent potency, controlled release, and desirable pharmacokinetics remain a challenge. The article delves into its diverse formulations obtained along with its routes of administration. The article provides an overview of cannabinoids-based formulations, highlighting their significance in the context of emerging therapeutic and commercial opportunities, while acknowledging the need for further research to optimize formulations and maximize benefits.

Year 2024 | Volume No. 61 | Issue No.10 | Page No. 7-20
Recent Issue
Current Issue
November 2024
Quick Contact